{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:13:26Z","timestamp":1773321206813,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Benzodiazepines (BZDs) are readily available potent drugs that act as central depressants. These drugs are widely used, misused, and abused. For patients with BZD use disorder, the traditional sobriety monitoring method is periodic urine tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The utility of eye-scanning data related to non-convergence (the ability to cross eyes) collected using smartphones with the Previct Drugs app before and after ingestion of the BZD lorazepam for detecting BZD-driven effects was evaluated using data from 12 individuals from a historic clinical study (NCT05731999). Using a novel metric that represents the change in distance between irises when converging eyes, either in absolute terms (NCdiff) or individualized (NCdiffInd), classifiers were built using logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The ability to converge eyes is a strongly individual and acquired skill that is impaired after ingesting lorazepam. The maximum NCdiff for a BZD-sober individual may be smaller than the impaired NCdiff for another individual. Using the NCdiff measured in a sober condition after approximately 1\u2005week of regular eye-scanning as the individual baseline to form NCdiffInd produced a highly functional classifier with an area under the curve (AUC)\u2009=\u20090.88, which was superior to a classifier based on NCdiff with an AUC\u2009=\u20090.79.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The loss of eye convergence induced by lorazepam is continuous, individual, and can be partial. Smartphone-based eye-scanning technology combined with a classifier adapted to the ability of eye convergence of individuals shows promising performance in detecting ingestion of lorazepam.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fdgth.2025.1584716","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:43:25Z","timestamp":1748583805000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Detecting benzodiazepine use through induced eye convergence inability with a smartphone app: a proof-of-concept study"],"prefix":"10.3389","volume":"7","author":[{"given":"Kiki W. K.","family":"Kuijpers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku D.","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Zetterstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Winkvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke","family":"Niesters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"van Velzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"B1","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"18m12174","DOI":"10.4088\/JCP.18m12174","article-title":"Prevalence and correlates of benzodiazepine use, misuse, and use disorders among adults in the United States","volume":"79","author":"Blanco","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"B3","first-page":"260","article-title":"Benzodiazepine use disorder: common questions and answers","volume":"108","author":"Robertson","year":"2023","journal-title":"Am Fam Physician"},{"key":"B4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"B5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.9740\/mhc.2016.05.120","article-title":"Benzodiazepine use, misuse, and abuse: a review","volume":"6","author":"Schmitz","year":"2016","journal-title":"Ment Health Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/fcp.12678","article-title":"Characterization of benzodiazepine misuse and comorbidities in patients with alcohol use disorder","volume":"35","author":"Lopez","year":"2021","journal-title":"Fundam Clin Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-244X-11-90","article-title":"Benzodiazepine use and misuse among patients in a methadone program","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"542","DOI":"10.21037\/apm.2019.12.09","article-title":"Combining opioids and benzodiazepines: effects on mortality and severe adverse respiratory events","volume":"9","author":"Boon","year":"2020","journal-title":"Ann Palliat Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/j.1360-0443.1994.tb03755.x","article-title":"The treatment of benzodiazepine dependence","volume":"89","author":"Ashton","year":"1994","journal-title":"Addiction"},{"key":"B10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1360-0443.1991.tb03422.x","article-title":"In-patient withdrawal from long-term benzodiazepine use","volume":"86","author":"Joughin","year":"1991","journal-title":"Br J Addict"},{"key":"B11","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2165\/11533170-000000000-00000","article-title":"The relationship between benzodiazepine use and traffic accidents: a systematic literature review","volume":"24","author":"Smink","year":"2010","journal-title":"CNS Drugs"},{"key":"B12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2165\/11539050-000000000-00000","article-title":"Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence","volume":"34","author":"Dassanayake","year":"2011","journal-title":"Drug Saf"},{"key":"B13","doi-asserted-by":"publisher","first-page":"956892","DOI":"10.3389\/fpsyt.2022.956892","article-title":"Study protocol-evoked craving in high-dose benzodiazepine users","volume":"13","author":"Zamboni","year":"2022","journal-title":"Front Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/10408363.2020.1774493","article-title":"What the lab can and cannot do: clinical interpretation of drug testing results","volume":"57","author":"Kapur","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2478\/aiht-2020-71-3315","article-title":"Effect of urine adulterants on commercial drug abuse screening test strip results","volume":"71","author":"Raj\u0161i\u0107","year":"2020","journal-title":"Arh Hig Rada Toksikol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/dta.2447","article-title":"Systematic investigations of novel validity parameters in urine drug testing and prevalence of urine adulteration in a two-year cohort","volume":"10","author":"Kluge","year":"2018","journal-title":"Drug Test Anal"},{"key":"B17","first-page":"E559","article-title":"Ethical perspectives on urine drug screening for pain physicians","volume":"17","author":"Kaye","year":"2014","journal-title":"Pain Physician"},{"key":"B18","article-title":"Substance abuse: clinical issues in intensive outpatient treatment","volume-title":"Treatment Improvement Protocol (TIP) Series 47","author":"Forman","year":"2006"},{"key":"B19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.aap.2015.10.019","article-title":"The standardized field sobriety tests (SFST) and measures of cognitive functioning","volume":"86","author":"Downey","year":"2016","journal-title":"Accid Anal Prev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jflm.2008.04.002","article-title":"The relation between the blood benzodiazepine concentration and performance in suspected impaired drivers","volume":"15","author":"Smink","year":"2008","journal-title":"J Forensic Leg Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF02246954","article-title":"Benzodiazepine pharmacodynamics: utility of eye movement measures","volume":"110","author":"Roy-Byrne","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"B22","first-page":"99","article-title":"Effects of lorazepam on vision and oculomotor balance","volume":"16","author":"Speeg-Schatz","year":"2001","journal-title":"Binocul Vis Strabismus Q"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2723","DOI":"10.1002\/hup.2723","article-title":"Assessing the validity of eyelid parameters to detect impairment due to benzodiazepines","volume":"35","author":"Wilkinson","year":"2020","journal-title":"Hum Psychopharmacol"},{"key":"B24","volume-title":"Drug Recognition Expert School, Participant Material","year":"2023"},{"key":"B25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4103\/ijmr.IJMR_1210_17","article-title":"Illicit drugs: effects on eye","volume":"150","author":"Dhingra","year":"2019","journal-title":"Indian J Med Res"},{"key":"B26","article-title":"Clinical investigation KCClin01 NCT05731999","author":"H\u00e4m\u00e4l\u00e4inen","year":"2025"},{"key":"B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00213-007-0884-y","article-title":"Arousal and the pupil: why diazepam-induced sedation is not accompanied by miosis","volume":"195","author":"Hou","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1365-2125.2006.02632.x","article-title":"Relationship between sedation and pupillary function: comparison of diazepam and diphenhydramine","volume":"61","author":"Hou","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1492246","DOI":"10.3389\/fnins.2024.1492246","article-title":"Eye reactions under the influence of drugs of abuse as measured by smartphones: a controlled clinical study in healthy volunteers","volume":"18","author":"Kuijpers","year":"2024","journal-title":"Front Neurosci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.optom.2021.11.002","article-title":"Convergence insufficiency: review of clinical diagnostic signs","volume":"15","author":"Gantz","year":"2022","journal-title":"J Optom"},{"key":"B31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/alcalc\/agy011","article-title":"Real-time monitoring using a breathalyzer-based eHealth system can identify lapse\/relapse patterns in alcohol use disorder patients","volume":"53","author":"H\u00e4m\u00e4l\u00e4inen","year":"2018","journal-title":"Alcohol Alcohol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/alcalc\/agaa004","article-title":"Breathalyser-based eHealth data suggest that self-reporting of abstinence is a poor outcome measure for alcohol use disorder clinical trials","volume":"55","author":"H\u00e4m\u00e4l\u00e4inen","year":"2020","journal-title":"Alcohol Alcohol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"732049","DOI":"10.3389\/fdgth.2021.732049","article-title":"The clinical course of alcohol use disorder depicted by digital biomarkers","volume":"3","author":"Zetterstr\u00f6m","year":"2021","journal-title":"Front Digit Health"},{"key":"B34","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/add.15211","article-title":"Post-mortem toxicological analyses of blood samples from 107 patients receiving opioid agonist treatment: substances detected and pooled opioid and benzodiazepine concentrations","volume":"116","author":"Bech","year":"2021","journal-title":"Addiction"},{"key":"B35","doi-asserted-by":"publisher","first-page":"109800","DOI":"10.1016\/j.drugalcdep.2023.109800","article-title":"Crash-involved THC-positive drivers in Norway have a high frequency of polysubstance use","volume":"244","author":"Gjerde","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1282022","DOI":"10.3389\/fdgth.2023.1282022","article-title":"Evaluation of 6 years of eHealth data in the alcohol use disorder field indicates improved efficacy of care","volume":"5","author":"Wallden","year":"2024","journal-title":"Front Digit Health"},{"key":"B37","article-title":"\u201cSmartphone based drug detection applied in addiction care: experiences from introduction of the tool in real patient cohorts\u201d scientific tracks abstracts","volume":"27","author":"H\u00e4m\u00e4l\u00e4inen","year":"2024","journal-title":"J Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/07853899009148934","article-title":"Alcohol and GABA-benzodiazepine receptor function","volume":"22","author":"Ticku","year":"1990","journal-title":"Ann Med"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2025.1584716\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:43:27Z","timestamp":1748583807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2025.1584716\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":38,"alternative-id":["10.3389\/fdgth.2025.1584716"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2025.1584716","relation":{},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"article-number":"1584716"}}